Abstract: The present invention relates to bi- and oligonuclear metal complexes and to electronic devices, especially organic electroluminescent devices, comprising these metal complexes.
Abstract: The present invention is related to a method for the production of single crystalline TiO2 flakes in the rutile crystal structure, to single crystalline TiO2 flakes obtained by this method as well as to the use thereof, especially as pigments in several application media.
Abstract: The present invention relates to a color conversion sheet (100) and an optical device comprising a color conversion sheet (100). The present invention further relates to a use of the color conversion sheet (100) in an optical device (200). The invention further more relates to method for preparing the color conversion sheet (100) and method for preparing the optical device (200).
Type:
Application
Filed:
March 29, 2017
Publication date:
May 23, 2019
Applicants:
Merck Patent GmbH, AZ Electronic Materials (Luxembourg) S.A.R.L.
Inventors:
Bernhard RIEGER, Christian MATUSCHEK, Ralf GROTTENMUELLER
Abstract: The present invention relates to organic electronic devices, and more specifically to organic field effect transistors, comprising a dielectric layer that comprises a polycycloolefinic polymer and a diazirine compound.
Type:
Application
Filed:
January 25, 2019
Publication date:
May 23, 2019
Applicants:
PROMERUS, LLC, MERCK PATENT GMBH
Inventors:
LARRY F RHODES, HUGH BURGOON, IRINA AFONINA, TOMAS BACKLUND, AURELIE MORLEY
Abstract: The present invention relates to liquid crystalline media comprising one or more benzothiadiazol derivatives of formula I, in which R11, R12, A11, A12, A21, A22, Z11, Z12, Z21, Z22, W, X11, X12, r and s have the meanings indicated in claim 1, to the use of such liquid crystal media for optical, electro-optical and electronic purposes, in particular in devices for regulating the passage of energy from an outside space into an inside space, for example in windows.
Type:
Application
Filed:
July 17, 2017
Publication date:
May 23, 2019
Applicant:
Merck Patent GmbH
Inventors:
Peer KIRSCH, Andreas RUHL, Michael JUNGE, Ursula PATWAL, Mila FISCHER
Abstract: Compounds of formula (I) are inhibitors of LMP7 and can be employed, inter alia, for the treatment of an autoimmune disorder or hematological malignancies.
Type:
Grant
Filed:
October 1, 2015
Date of Patent:
May 21, 2019
Assignee:
MERCK PATENT GMBH
Inventors:
Markus Klein, Oliver Schadt, Philipp Haselmayer, Michael Busch
Abstract: The present invention relates to liquid-crystalline media (LC media) having negative or positive dielectric anisotropy, comprising a low-molecular-weight component and a polymerizable component. The polymerizable component comprises self-aligning, polymerizable mesogens (polymerizable self-alignment additives) which effect homeotropic (vertical) alignment of the LC media at a surface or the cell walls of a liquid-crystal display (LC display). The invention therefore also encompasses LC displays having homeotropic alignment of the LC medium without alignment layers. The invention discloses novel structures for polymerizable self-alignment additives which have a certain position of the functional groups.
Type:
Grant
Filed:
June 25, 2015
Date of Patent:
May 21, 2019
Assignee:
MERCK PATENT GMBH
Inventors:
Graziano Archetti, Izumi Saito, Rocco Fortte, Oliver Heppert, Andreas Taugerbeck, Elena Neumann
Abstract: A method can treat a patient suffering from at least one of fibrosis and a fibrotic disorder. The method includes administering a therapeutically effective amount of an anti-?v integrin antibody DI17E6, or a biologically active variant or modification thereof, to the patient.
Abstract: The present invention relates to organic dielectric layers comprising a polycycloolefinic polymer with a pendent chromophoric group having an absorption maximum in the wavelength range from 230 to 290 nm, and to organic electronic devices comprising them.
Type:
Application
Filed:
May 15, 2017
Publication date:
May 16, 2019
Applicants:
PROMERUS, LLC, MERCK PATENT GMBH
Inventors:
IRINA AFONINA, TOMAS BACKLUND, LARRY F RHODES, HUGH A BURGOON
Abstract: The invention relates to methods of treating cancer in a subject, comprising administering to the subject a therapeutically effective amount of an inhibitor of the interaction between the PD-1 receptor and its ligand PD-L1.
Type:
Application
Filed:
May 22, 2017
Publication date:
May 16, 2019
Applicants:
MERCK PATENT GMBH, PFIZER INC.
Inventors:
Dimitry NUYTEN, Alexei MOROZOV, Adrian WOOLFSON, Aron THALL, Kevin CHIN, Satjit BRAR
Abstract: The present invention relates to bisimidazolium salts, to novel mono- and biscarbenes derived therefrom, and to metal complexes which contain corresponding mono- and biscarbenes as ligands, to a process for the preparation of the bisimidazolium salts according to the invention, the mono- and biscarbenes according to the invention and to the metal complexes according to the invention, and to the use of the bisimidazolium salts according to the invention, the mono- and biscarbenes according to the invention and to the use of the metal complexes according to the invention.
Abstract: The present invention relates to laser-markable and laser-weldable polymeric materials which are distinguished by the fact that they comprise, as laser absorber, at least one copper-doped zinc sulfide.
Type:
Grant
Filed:
November 18, 2015
Date of Patent:
May 14, 2019
Assignee:
Merck Patent GmbH
Inventors:
Reinhold Rueger, Ulrich Quittmann, Silvia Rosenberger
Abstract: The invention provides novel imidazol-piperidinyl derivatives of the formula (I) in which R1, R2, W, X1, X2, X3, X4 and n have the meanings indicated in formula I, and their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.
Type:
Grant
Filed:
November 20, 2017
Date of Patent:
May 14, 2019
Assignee:
Merck Patent GmbH
Inventors:
Ruoxi Lan, Bayard R. Huck, Xiaoling Chen, Yufang Xiao
Abstract: The present invention relates to the use of an amino sugar as plasticizer in formulations comprising a polymer as carrier for active ingredients, in particular for compositions which are intensively mixed by treatment in a melt extrusion and then formulated by suitable post-treatment.
Abstract: The present invention relates to compounds of formula (1). The compounds are suitable for use in electronic devices, in particular organic electroluminescent devices, comprising these compounds.
Type:
Application
Filed:
April 26, 2017
Publication date:
May 9, 2019
Applicant:
Merck Patent GmbH
Inventors:
Amir PARHAM, Tobias GROSSMANN, Jonas KROEBER
Abstract: Compounds of the formula I in which X, Y, R1 and R2 have the meanings indicated in claim 1, are inhibitors of pyruvate dehydrogenase kinase (PDHK), and can be employed, inter alia, for the treatment of diseases such as cancer.
Abstract: The invention relates generally to cyclic peptides and their use in compositions, especially topical, cosmetic and/or personal care compositions, and compositions containing said cyclic peptides.
Abstract: The present invention relates to a process for the production of three-dimensional patterns in plastic mouldings, in particular to an injection-moulding process for the production of mouldings having a three-dimensional pattern, to the polymeric mouldings produced by means of this process, and to the use thereof, in particular for decorative purposes.
Abstract: The present invention relates to silver-colored effect pigments having a strong sparkle effect based on Al2O3 flakes and to the use thereof in paints, button pastes, automotive paints, automotive refinish paints, powder coatings, printing inks, security printing inks, plastics, ceramic materials, glasses, paper, for coating seed, in security applications, as dopant for the laser marking of plastics and papers, as additive for the laser welding of plastics, in cosmetic formulations and for the preparation of pigment preparations and dry preparations.
Type:
Grant
Filed:
March 11, 2015
Date of Patent:
May 7, 2019
Assignee:
MERCK PATENT GMBH
Inventors:
Johann Dietz, Cornelia Foerderer, Nicole Haferkorn, Gerhard Pfaff, Doreen McFarlane
Abstract: The present invention relates to compositions for nanoencapsulation which comprise the mesogenic medium as set forth in claim 1, one or more polymerizable compounds and one or more surfactants, to nanocapsules containing the mesogenic medium and to their use in electro-optical devices.
Type:
Application
Filed:
April 10, 2017
Publication date:
May 2, 2019
Applicant:
Merck Patent GmbH
Inventors:
Kevin ADLEM, Patricia SAXTON, Rachel TUFFIN, Benjamin SNOW, Mariam NAMUTEBI, James ALLEN, Vicki COOK, Hassan ARASI, Mark GOEBEL